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Conclusions: In this explorative study most patients awaiting TKR
experienced signiﬁcant levels of pain and limitations in activities, but
surprisingly the majority did not take NSAIDs daily. Patients with
inadequate medication, who started using NSAIDs daily, improved
clinically signiﬁcantly. Further, properly designed RCTs are warranted
to study the potential effect of adequate pain medication to delay the
need for total knee replacement surgery in case of severe OA, an area
where rheumatologists can support orthopaedics.
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ASSOCIATIONS BETWEEN CLINICAL FINDINGS AND MRI
OSTEOARTHRITIS FEATURES OF THE PATELLOFEMORAL JOINT
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E.H. Oei, B.W. Koes, S.M. Bierma-Zeinstra. Erasmus MC, Rotterdam,
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Purpose: The patellofemoral joint is important in osteoarthritis (OA)
of the knee, and in early detection of knee OA. Little is known
about the relationship of speciﬁc patellofemoral clinical ﬁndings and
patellofemoral MRI OA features. Therefore the purpose of this study
is to examine the relationship between clinical ﬁndings and MRI OA
features of patellofemoral joint in females aged 45 to 60 years without
radiological tibiofemoral OA.
Methods: In an open population of the Rotterdam Study (RS-I-1)
all women were invited for a sub-study of identiﬁcation of early
knee OA. Radiographs of the knees were made, as well as an MRI
of both knees. Radiographs were scored with Kellgren and Lawrence
classiﬁcation criteria. Cartilage defects, osteophytes, cysts, bone marrow
lesions and joint effusion were scored on the MRI’s. Furthermore a
physical examination of the knee was performed with speciﬁc patellar
tests and speciﬁc questions about pain in the knee and patellar knee pain
were reported in a questionnaire. Binomial logistic generalized estimated
equations were used to determine the association between the clinical
ﬁndings and MRI OA features of the patellofemoral joint (odds ratio (OR),
95% conﬁdence interval (CI)). All associations were adjusted for age, BMI
and MRI OA features of the tibiofemoral joint.
Results: In 776 women (1429 knees, mean age = 54.7 years and mean
BMI =26.7) we found signiﬁcant associations between crepitus and all
patellar MRI OA features (diffuse cartilage defects OR=5.26 (CI = 3.52–
7.85); focal cartilage defects OR=3.60 (CI = 2.28–5.69); osteophytes
OR=3.21 (CI = 2.45–4.22); cysts OR=2.73 (CI = 1.96–3.82); bone marrow
lesions OR=3.58 (CI = 2.65–4.83); joint effusion OR=1.51 (CI = 1.18–1.94).
And also between a history of patellar pain and the MRI OA features
(diffuse cartilage defects OR=2.44 (CI = 1.72–3.47); focal cartilage
defects OR=1.77 (CI = 1.15–2.71); osteophytes OR=1.68 (CI = 1.26–2.22);
cysts OR=2.06 (CI = 1.48–2.86); bone marrow lesions OR=2.18 (CI =
1.60–2.97); joint effusion OR=1.48 (CI = 1.13–1.93). Current knee pain
was signiﬁcantly associated with diffuse cartilage defects (OR=2.22,
CI = 1.38–3.59), cysts (OR=1.78, CI = 1.13–2.80), bone marrow lesions
(OR=2.11, CI = 1.39–3.19), and joint effusion (OR=1.75, CI = 1.23–2.51) at
PFJ. Furthermore patellar compression test was signiﬁcantly associated
with diffuse cartilage defects (OR=1.55, CI = 1.03–2.32), and pain at
tuberositas tibia was signiﬁcantly associated with focal cartilage defects
(OR=4.98, CI = 1.50–16.49).
Conclusions: Crepitus and a history of patellar pain are clinical ﬁndings
that indicate OA features at the patellofemoral joint in women without
radiographic tibiofemoral OA. These tests could help to indicate signs of
patellofemoral OA and follow-up data needs to conﬁrm whether these
tests have an additional diagnostic value on early stage knee OA.
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NSAIDS VERSUS ACETAMINOPHEN IN KNEE AND HIP
OSTEOARTHRITIS: A SYSTEMATIC REVIEW REGARDING
HETEROGENEITY INFLUENCING THE OUTCOMES
S.P. Verkleij, P.A. Luijsterburg, A.M. Bohnen, B.W. Koes, S.M. Bierma-
Zeinstra. Erasmus MC, Rotterdam, Netherlands
Purpose: Recent reviews reported only small improvements in pain
in favor of non-steroidal anti-inﬂammatory drugs (NSAIDs) compared
to acetaminophen in treating patients with osteoarthritis (OA), but
NSAIDs are consistently associated with substantially more side effects.
Systematic reviews integrate the results of original studies but if studies
are heterogeneous, there is no added value of pooling the results and
subgroup analyses may be needed. Statistical heterogeneity was reported
absent in systematic reviews that compared the effectiveness of NSAIDs
versus acetaminophen in treating patients with OA. Yet, clinical and
methodological heterogeneity are unknown.
The aim of our review was to identify sources of heterogeneity
(statistical, methodological, and clinical) in trials evaluating NSAIDs vs.
acetaminophen in patients with knee and hip OA to elucidate variations
in outcomes.
Methods: A search in relevant databases (1966-Jan 2010) was
made for (randomized) controlled trials ((R)CTs) comparing NSAIDs
vs. acetaminophen in knee and hip OA. Extracted data included
baseline demographic/clinical characteristics, outcomes at follow-up,
and characteristics of study design. Heterogeneity was examined with
subgroup-analyses by exploring changes in effect size and with I2
of Higgins. Pain measures were expressed as standardized mean
differences.
Results: 15 RCTs met the in- and exclusion criteria which included
21 comparisons of NSAIDs and acetaminophen. Statistical heterogeneity
was absent (Cochran’s Q-test=14.11; I2=0; p = 0.78). Moderate clinical
heterogeneity was found for comparisons which included both patients
with hip and knee OA vs. patients with knee OA only (I2=51; p =0.09).
NSAIDs seemed slightly more effective than acetaminophen if more
patients with hip OA were included. However, the pooled effect sizes
of comparisons with knee OA vs. both knee and hip OA are equal. Low
clinical heterogeneity was found for comparisons with low dosage of
acetaminophen, normal dosage of NSAIDs, and moderate pain intensity at
baseline. Low methodological heterogeneity was found for comparisons
with a short duration of follow-up.
Conclusions: Future trials should present the results of patients with hip
and knee OA separately, as moderate clinical heterogeneity was found.
There might be differences in effectiveness of NSAIDs vs. acetaminophen
in patients with hip vs. knee OA. No signiﬁcant methodological and
statistical heterogeneity was found in studies evaluating NSAIDs vs.
acetaminophen.
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PATIENT-ORIENTED OUTCOME MEASURE AND RISK OF KNEE
REPLACEMENT SURGERY FOR THE JAPANESE KNEE OSTEOARTHRITIS
PATIENTS WITH KELLEGREN-LAURENCE GRADE 4
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Y. Takazawa1, H. Ikeda1, K. Kaneko1,3. 1Dept. of Orthopaedics, Juntendo
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Purpose: Total knee arthroplasty (TKA) is an effective therapy to control
pain and improve function in subjects with severe knee osteoarthritis
(OA). However, as the decision whether to have a joint replacement
or not is more ambiguous, it is a judgment that has to be made by
the physician and patient working together, and it has to take account
of a disability of the patient, in addition to X-ray changes. It is also
revealed that there are regional differences for the indication of TKA.
For physicians, objective indicators which represent the past results of
patients already received TKA are helpful to discuss with patients who
are considering their decision to TKA.
The use of clinical outcomes in clinical medicine is important. The
Japanese Knee Osteoarthritis Measure (JKOM) was created as a patient-
oriented outcome measure for Japanese patients with knee OA. This
measure has proven to have sufﬁcient reliability and validity by means
of statistical evaluation and comparison with the WOMAC and SF-36.
The aim of this study was to examine whether the JKOM score can
predict the risk for receiving TKA, and, if so, the cut-off of JKOM score
can be set for receiving TKA.
Methods: This study protocol was approved by the institutional review
board of our university. 227 painful medial knee OA patients with
K/L 4 were enrolled in this study. JKOM score was obtained from all
subjects on the day that radiographs taken. The signiﬁcant differences
of the data were evaluated using the Mann Whitney-U test. The AUC,
which is analogous to the area under the ROC curve, was estimated for
the discriminative value of prediction models. Odds ratios (ORs) were
calculated to evaluate the JKOM cut-off score for receiving TKA.
Results: In this study, patients were followed for 6 months on average.
While 63% of the patients were received TKA (OP group), remaining 37%
